SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : NIFTY NINE IN NINETY NINE PLUS ONE -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (149)1/16/1999 7:16:00 PM
From: Arthur Radley  Respond to of 613
 
atrixlabs.com
They have an excellent website IMO. Still doing some DD on them and Scott's question of why the recent drop needs further looking into. The drop from 21.00 to below 10.00 just when good news is apparently starting to flow from the company gives me pause. Looks like full year earnings are expected to be excellent, but one source I've looked at indicates a loss projected for 1999. I wonder if 1998 is being influenced by milestone payments from Block and that 1999 will only have royalty payments as a source of income. I would like to think this isn't the case and the report hasn't be updated to reflect positive earnings for 1999. Let me know what you find.



To: Steve Lokness who wrote (149)1/18/1999 12:02:00 PM
From: Arthur Radley  Read Replies (2) | Respond to of 613
 
Steve,
The article was published in Nature Medicine two weeks ago. It dealt with two scientific groups reporting on successful treating hemophilia B in mice and dogs with gene therapy. They sent genes into the body aboard a virus that is not attacked by the immune system.

Hope this helps. If you find the article would like your opinion of the process.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News